Skip to main content


If you are a woman in otherwise good health with a body mass index (BMI) under 30, who developed diabetes while taking Lipitor (atorvastatin) to lower your blood cholesterol and/or promote good cardiac health, you may have a case against Lipitor’s manufacturer, Pfizer. Do not hesitate to schedule a consultation with a lawyer at our Williamsport office.

Pfizer required by FDA to change label in 2012

In February, 2012, Pfizer and the manufactures of other statin drugs on the market commonly used to treat elevated blood cholesterol were required by the FDA to change the drug’s label to state that “increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor.”

Lipitor can increase the risk factor for Type 2 Diabetes

Recent studies have supported that Lipitor provides little cardiac benefit in women, while can increase the risk for developing Type 2 diabetes while taking the drug.

A study published in the British Medical Journal on May 23, 2013 found that statins that were at a higher potency may place patients at an increased risk for developing Type 2 diabetes. In that study, researchers found an increased risk of diabetes with patients given atorvastatin (Lipitor) and with simvastatin, but no increased risk with lower potency statin drugs.

Are you a Woman Who Developed Diabetes While Taking Lipitor – The Rieders Travis Firm May Be Able to Help You

Another study, published in January 2012 in the Archives of Internal Medicine found that women aged 50-70 who took Lipitor were 48% more likely to develop diabetes.

In addition on March 28, 2011 , a meta analysis from three clinical trials was published supporting increase in type 2 diabetes with Lipitor particularly in patients who have other risk factors. This study was published in the Journal of American Cardiology, and showed that the risk of developing diabetes with Lipitor was much greater when other risk factors were present for developing Type 2 diabetes.

An unpublished study that Pfizer conducted years ago shows that Lipitor provides no protective cardiac benefit in women, such as reducing myocardial infarctions (heart attacks). Pfizer chose not to publish this study.

There is a group of coordinated litigations that have been filed by women who developed type 2 diabetes while taking Lipitor in federal court, although there is not yet a multi-district litigation (MDL). The next meeting of the joint panel on multidistrict litigation meets in December, at which time hopefully MDL status will be granted to the ongoing Lipitor litigations in federal district court for the District of South Carolina. Our Pennsylvania Lipitor lawsuit attorneys can provide the guidance you need.

Free Lipitor case evaluation

inner-content-img3If you suspect Lipitor use for more than six months caused your to develop diabetes while taking Lipitor you need legal help so you can seek justice. Contact us today to learn of your legal rights and determine whether you may be able to obtain compensation for your injury. You must be a woman with a body mass index (BMI) under 30 and must have developed diabetes while taking Lipitor. We will need to obtain your medical records to determine whether you may have a case. Call our attorneys at Rieders, Travis, Dohrmann, Mowrey, Humphrey & Waters, 570-323-8711, to see whether you may be entitled to compensation from the harm caused by Pfizer from Lipitor.

Attorney Cliff Rieders

Attorney Cliff RiedersCliff Rieders is a Nationally Board Certified Trial Lawyer practicing personal injury law. A large part of his practice involves multi-district litigation, including cases related to pharmaceuticals, vitamin supplements and medical devices. He is admitted in several state and federal courts, as well as the Supreme Court of the United States. Rieders is the past regional president of the Federal Bar Association and is a life member of the distinguished American Law Institute, which promulgates proposed rules adopted by many state courts. He is a past president of the Pennsylvania Association for Justice, formerly Pennsylvania Trial Lawyers Association. As a founder of the Pennsylvania Patient Safety Authority, he served on the Board for 15 years.

Not only has Rieders held many highly esteemed, leadership positions, he authored legislation related to the Patient Safety Authority and the Mcare Act, which governs medical and hospital liability actions in Pennsylvania. He authored texts upon which both practitioners and judges rely, including Pennsylvania Malpractice Laws and Forms, and Financial Responsibility Law Issues in Pennsylvania, the latter governing auto and truck collisions in Pennsylvania. In addition, he wrote several books on the practice of law in Pennsylvania regarding wrongful death and survivor actions, insurance bad faith, legal malpractice claims and worker rights, among others. Rieders also serves as a resource to practitioners as a regular speaker for Celesq, an arm of the world’s largest legal publisher, Thomson Reuters West Publishing.

As recognition of his wide range of contribution to his profession and of his dedication to protecting the rights of his clients, he received numerous awards, among them the George F. Douglas Amicus Curiae Award, the Milton D. Rosenberg Award, the B’nai B’rith Justice Award, and awards of recognition from the Pennsylvania Trial Lawyers. [ Attorney Bio ]